Objective of the study: To investigate the effectiveness of trimetazidine and its combination with methyldopa with preeclampsia in an experiment.
Methods: The experiment was performed in 140 white female Wistar rats weighing 250-300 g. L-NAME was administered intraperitoneally (25 mg / kg / day) from 14 to 20 days of gestation. Trimetazidine (6 mg / kg) was administered intragastrically 1 time per day from 14 to 20 days of pregnancy. Methyldopa (2x0.043 g / kg) was administered 2 times a day from 14 to 20 days of pregnancy. On 21 days of pregnancy, functional tests and laboratory tests were performed.
Results: The admistration in animals of trimetazidine leads to a pronounced correction of pathological changes in experimental ADMA-like preeclampsia. The greatest effect was observed with combined methyldopa. A significant decrease in systolic and diastolic pressure was noted, respectively, improved microcirculation in the placenta, restoration of the NO-synthesizing endothelial function, and a decrease in proteinuria.
Conclusion: The results of the study indicate the promise of using trimetazidine for the correction of morphological and functional changes in preeclampsia and substantiate the feasibility of further studies in this direction.
Trimetazidine, Preeclapsia, Endothelial Dysfunction, Rats, Proteinuria, Microcirculation.
Generating Monocyte-Derived Endothelial-like Cells for Vascular Regeneration.
Smith RJ, Andreadis ST
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 13-19
Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12
Health-seeking behaviour, views and preferences of adults with suspected increased intestinal permeability: A cross-sectional survey of Australian adults.
Leech B, McIntyre E, Steel A, Sibbritt D
Integrative medicine research. 2022; 11(1): 100757
Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects.
Rey F, Ottolenghi S, Zuccotti GV, Samaja M, Carelli S
Neural regeneration research. 2022; 17(4): 754-758
Use of Cocultures to Measure the Blood-Brain Barrier Permeability of Oxytocin.
Yamamoto Y, Harashima A, Munesue SI, Higashida H
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 247-255